Therapeutic restoration of endothelial glycocalyx in sepsis

Journal of Pharmacology and Experimental Therapeutics

Volumn 361, Issue 1, 2017, Pages 115-121

  Song, J W ^b   Zullo, J A ^a   Liveris, D ^a   Dragovich, M ^c   Zhang, X F ^c   Goligorsky, M S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Yonsei University College of Medicine   (South Korea)

^c Lehigh University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVANS BLUE; HEPARANASE; LIPOPOLYSACCHARIDE; SULODEXIDE; ANTICOAGULANT AGENT; GLYCOSAMINOGLYCAN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIUM CULTURE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIAL GLYCOCALYX; ENDOTHELIUM CELL; GLYCOCALYX; IN VITRO STUDY; IN VIVO STUDY; LUNG; MALE; MOUSE; NONHUMAN; PATHOGEN LOAD; PERITONEAL FLUID; SEPSIS; SURVIVAL RATE; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL CULTURE; DRUG EFFECTS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTICOAGULANTS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; GLYCOCALYX; GLYCOSAMINOGLYCANS; MALE; MICE; MICE, INBRED C57BL; SEPSIS;

EID: 85018484179     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.116.239509     Document Type: Article

References (40)

1. Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765-3777.
2. Becker BF, Chappell D, Bruegger D, Annecke T, and Jacob M (2010a) Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 87:300-310.
3. Becker BF, Chappell D, and Jacob M (2010b) Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 105:687-701.
4. Becker BF, Jacob M, Leipert S, Salmon AH, and Chappell D (2015) Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol 80:389-402.
5. Chappell D, Heindl B, Jacob M, Annecke T, Chen C, Rehm M, Conzen P, and Becker BF (2011) Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx. Anesthesiology 115:483-491.
6. Chelazzi C, Villa G, Mancinelli P, De Gaudio AR, and Adembri C (2015) Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care 19:26.
7. Coccheri S and Mannello F (2014) Development and use of sulodexide in vascular diseases: implications for treatment. Drug Des Devel Ther 8:49-65.
8. Dragovich MA, Chester D, Fu BM, Wu C, Xu Y, Goligorsky MS, and Zhang XF (2016) Mechanotransduction of the endothelial glycocalyx mediates nitric oxide production through activation of TRP channels. Am J Physiol Cell Physiol 311: C846-C853.
9. Evanko SP, Tammi MI, Tammi RH, and Wight TN (2007) Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 59:1351-1365.
10. Fraser JR, Laurent TC, and Laurent UB (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27-33.
11. Ghosh CC, Mukherjee A, David S, Knaus UG, Stearns-Kurosawa DJ, Kurosawa S, and Parikh SM (2012) Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax. Proc Natl Acad Sci USA 109:10024-10029.
12. Giantsos-Adams KM, Koo AJ, Song S, Sakai J, Sankaran J, Shin JH, Garcia-Cardena G, and Dewey CF, Jr (2013) Heparan sulfate regrowth profiles under laminar shear flow following enzymatic degradation. Cell Mol Bioeng 6:160-174.
13. Guan H, Nagarkatti PS, and Nagarkatti M (2007) Blockade of hyaluronan inhibits IL-2-induced vascular leak syndrome and maintains effectiveness of IL-2 treatment for metastatic melanoma. J Immunol 179:3715-3723.
14. Henry CB and Duling BR (1999) Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 277:H508-H514.
15. Hoppensteadt DA and Fareed J (2014) Pharmacological profile of sulodexide. Int Angiol 33:229-235.
16. Jiang D, Liang J, and Noble PW (2007) Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23:435-461.
17. Kaneider NC, Förster E, Mosheimer B, Sturn DH, and Wiedermann CJ (2003) Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin. Thromb Haemost 90:1150-1157.
18. Kusche-Vihrog K and Oberleithner H (2012) An emerging concept of vascular salt sensitivity. F1000 Biol Rep 4:20.
19. Lipowsky HH, Sah R, and Lescanic A (2011) Relative roles of doxycycline and cation chelation in endothelial glycan shedding and adhesion of leukocytes. Am J Physiol Heart Circ Physiol 300:H415-H422.
20. Mannello F, Medda V, Ligi D, and Raffetto JD (2013) Glycosaminoglycan sulodexide inhibition ofMMP-9 gelatinase secretion and activity: possible pharmacological role against collagen degradation in vascular chronic diseases. Curr Vasc Pharmacol 11:354-365.
21. Mannello F and Raffetto JD (2011) Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. Am J Transl Res 3:149-158.
22. Masola V, Onisto M, Zaza G, Lupo A, and Gambaro G (2012) A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition. J Transl Med 10:213.
23. Morrison DC and Ulevitch RJ (1978) The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol 93:526-618.
24. Nieuwdorp M, Mooij HL, Kroon J, Atasever B, Spaan JA, Ince C, Holleman F, Diamant M, Heine RJ, Hoekstra JB, et al. (2006a) Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55:1127-1132.
25. Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, Holleman F, Hoekstra JB, Vink H, et al. (2006b) Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55:480-486.
26. Oberleithner H (2013) Vascular endothelium leaves fingerprints on the surface of erythrocytes. Pflugers Arch 465:1451-1458.
27. Oberleithner H, Peters W, Kusche-Vihrog K, Korte S, Schillers H, Kliche K, and Oberleithner K (2011) Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch 462:519-528.
28. Potter DR and Damiano ER (2008) The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ Res 102:770-776.
29. Ratliff BB, Rabadi MM, Vasko R, Yasuda K, and Goligorsky MS (2013) Messengers without borders: mediators of systemic inflammatory response in AKI. J Am Soc Nephrol 24:529-536.
30. Reitsma S, Slaaf DW, Vink H, van Zandvoort MAMJ, and oude Egbrink MGA (2007) The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 454:345-359.
31. Spicer A and Calfee CS (2012) Fixing the leak: targeting the vascular endothelium in sepsis. Crit Care 16:177.
32. van den Berg BM, Vink H, and Spaan JA (2003) The endothelial glycocalyx protects against myocardial edema. Circ Res 92:592-594.
33. VanTeeffelen JW, Brands J, and Vink H (2010) Agonist-induced impairment of glycocalyx exclusion properties: contribution to coronary effects of adenosine. Cardiovasc Res 87:311-319.
34. Vlasenko LP and Melendez AJ (2005) A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo. J Immunol 174:6456-6461.
35. Vlodavsky I, Ilan N, Naggi A, and Casu B (2007) Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 13:2057-2073.
36. Weinbaum S, Tarbell JM, and Damiano ER (2007) The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 9:121-167.
37. WiesingerA, PetersW, ChappellD,KentrupD, Reuter S, PavenstädtH, Oberleithner H, and Kümpers P (2013) Nanomechanics of the endothelial glycocalyx in experimental sepsis. PLoS One 8:e80905.
38. Zhang J, Skardal A, and Prestwich GD (2008) Engineered extracellular matrices with cleavable crosslinkers for cell expansion and easy cell recovery. Biomaterials 29: 4521-4531.
39. Zullo JA (2016) Mechanisms of Glycocalyx Loss at the Onset of Sepsis andManeuvers for its Preservation and Regeneration Ph.D. thesis, New York Medical College, Valhalla, NY.
40. Zullo JA, Fan J, Azar TT, Yen W, Zeng M, Chen J, Ratliff BB, Song J, Tarbell JM, Goligorsky MS, et al. (2016) Exocytosis of endothelial lysosome-related organelles hairtriggers a patchy loss of glycocalyx at the onset of sepsis. Am J Pathol 186:248-258.